 | |
| Legal status | |
|---|---|
| Legal status |
|
| Identifiers | |
| |
| PubChem CID | |
| ChemSpider | |
| Chemical and physical data | |
| Formula | C16H22FNO |
| Molar mass | 263.356 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
MFPVP (3-Methyl-4-fluoro-α-pyrrolidinovalerophenone) is a recreational designer drug from the substituted cathinone family, with stimulant effects. It was first identified in Sweden in April 2020 and was among the most widely encountered substituted cathinone derivatives in 2021, though it since appears to have declined in prevalence.[1][2][3] It is illegal in Virginia.[4]
See also
References
- ^ European Monitoring Center for Drugs and Drug Addiction (December 2020). New psychoactive substances: global markets, glocal threats and the COVID-19 pandemic. An update from the EU Early Warning System (PDF). Luxembourg: Publications Office of the European Union. doi:10.2810/921262. ISBN 9789294975584.
- ^ Hobbs JM, DeRienz RT, Baker DD, Shuttleworth MR, Pandey M (March 2022). "Fatal Intoxication by the Novel Cathinone 4-Fluoro-3-methyl-α-PVP". Journal of Analytical Toxicology. 46 (3): e101–e104. doi:10.1093/jat/bkac003. PMID 35020879.
- ^ Kuropka P, Zawadzki M, Szpot P (2023). "A review of synthetic cathinones emerging in recent years (2019-2022)". Forensic Toxicology. 41 (1): 25–46. doi:10.1007/s11419-022-00639-5. PMC 9476408. PMID 36124107.
- ^ Code of Virginia 54.1-3446.
 | This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |
This page was last edited on 13 September 2023, at 08:14